Versant Venture Capital Vi, L.P. Oyster Point Pharma, Inc. (OYST) insider trading activity

Versant Venture Capital VI, L.P. Transaction History

Date	Transaction	Value	Shares Traded
Jan 03 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	1,420,730
Jan 05 2022	SELL Other acquisition or disposition	-	253,030
Jan 05 2022	BUY Other acquisition or disposition	-	51,556
Dec 21 2021	SELL Other acquisition or disposition	-	253,030
Dec 21 2021	BUY Other acquisition or disposition	-	51,556
Oct 18 2021	SELL Open market or private sale	$8,173,000 $14.86 p/Share	550,000
May 12 2021	SELL Other acquisition or disposition	-	404,844
May 12 2021	BUY Other acquisition or disposition	-	82,486
Mar 26 2021	SELL Other acquisition or disposition	-	404,849
Mar 26 2021	BUY Other acquisition or disposition	-	82,491
Feb 17 2021	SELL Other acquisition or disposition	-	12,107
Feb 17 2021	BUY Other acquisition or disposition	-	12,107

BDTX

Black Diamond Therapeutics, Inc. Healthcare

ALGS

Aligos Therapeutics, Inc. Healthcare

> 10% Shareholder

IPSC

Century Therapeutics, Inc. Healthcare

> 10% Shareholder

GLUE

Monte Rosa Therapeutics, Inc. Healthcare

GRPH

Graphite Bio, Inc. Healthcare

CTNM

Contineum Therapeutics, Inc.

> 10% Shareholder

TPST

Tempest Therapeutics, Inc. Healthcare

VVC

> 10% Shareholder

San Francisco, CA

Receive a notification when an Institution or Guru buys or sells OYST shares.

Notify only if

Value

Get notified when an Oyster Point Pharma, Inc. insider buys or sells OYST shares.

Notify only if

Operation

Value

Type

Receive news related to Oyster Point Pharma, Inc.